The impact of chronic kidney disease on prognosis in acute stroke: unraveling the pathophysiology and clinical complexity for optimal management
- 3 December 2024
- journal article
- review article
- Published by Springer Nature in Clinical and Experimental Nephrology
- Vol. 29 (2) , 149-172
Abstract
Background Chronic kidney disease (CKD) significantly increases stroke risk and severity, posing challenges in both acute management and long-term outcomes. CKD contributes to cerebrovascular pathology through systemic inflammation, oxidative stress, endothelial dysfunction, vascular calcification, impaired cerebral autoregulation, and a prothrombotic state, all of which exacerbate stroke risk and outcomes. Methods This review synthesizes evidence from peer-reviewed literature to elucidate the pathophysiological mechanisms linking CKD and stroke. It evaluates the efficacy and safety of acute reperfusion therapies—intravenous thrombolysis and endovascular thrombectomy—in CKD patients with acute ischemic stroke. Considerations, such as renal function, drug dosage adjustments, and the risk of contrast-induced nephropathy, are critically analyzed. Evidence-based recommendations and research priorities are drawn from an analysis of current practices and existing knowledge gaps. Results CKD influences stroke outcomes through systemic and local pathophysiological changes, necessitating tailored therapeutic approaches. Reperfusion therapies are effective in CKD patients but require careful monitoring of renal function to mitigate risks, such as contrast-induced nephropathy and thrombolytic complications. The bidirectional relationship between stroke and CKD highlights the need for integrated management strategies to address both conditions. Early detection and optimized management of CKD significantly reduce stroke-related morbidity and mortality. Conclusion Optimizing stroke care in CKD patients requires a comprehensive understanding of their pathophysiology and clinical management challenges. This article provides evidence-based recommendations, emphasizing individualized treatment decisions and coordinated care. It underscores the importance of integrating renal considerations into stroke treatment protocols and highlights the need for future research to refine therapeutic strategies, address knowledge gaps, and consider tailored interventions to improve outcomes and quality of life for this high-risk population. Graphical AbstractKeywords
Funding Information
- Japan Society for the Promotion of Science (P23712)
This publication has 186 references indexed in Scilit:
- Mortality and Morbidity Among Individuals With Hypertension Receiving a Diuretic, ACE Inhibitor, or Calcium Channel BlockerJAMA Network Open, 2023
- Antiplatelet agents for chronic kidney diseaseCochrane Database of Systematic Reviews, 2022
- Younger age of stroke in low‐middle income countries is related to healthcare access and qualityAnnals of Clinical and Translational Neurology, 2022
- Role of diabetes in stroke: Recent advances in pathophysiology and clinical managementDiabetes/Metabolism Research and Reviews, 2021
- Acute kidney injury after a stroke: A PRISMA‐compliant meta‐analysisBrain and Behavior, 2020
- Anticoagulation in chronic kidney disease: from guidelines to clinical practiceClinical Cardiology, 2019
- Thrombolysis for acute ischaemic strokeCochrane Database of Systematic Reviews, 2014
- Prevention of contrast induced nephropathy: Recommendations for the high risk patient undergoing cardiovascular proceduresCatheterization and Cardiovascular Interventions, 2006
- Prevalence of Conventional Risk Factors in Patients With Coronary Heart DiseaseJAMA, 2003
- Effect of Blood Pressure Lowering and Antihypertensive Drug Class on Progression of Hypertensive Kidney DiseaseResults From the AASK TrialJAMA, 2002